Boron-Containing Analogs of Fosmidomycin: Benzoxaborole Derivatives Exhibit Promising Activity Against Resistant Pathogens
Open Access
- 19 July 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (29) , 31722-31740
Abstract
The rise of antimicrobial resistance presents an urgent challenge that necessitates the development of novel therapeutic agents with distinct mechanisms of action. This research explores boron-containing compounds as potential neutral phosphate/phosphonate isosteres of fosmidomycin, a potent inhibitor of 1-deoxy-d-xylulose-5-phosphate reductoisomerase (IspC) within the nonmevalonate isoprenoid biosynthesis (MEP) pathway, with limited clinical utility due to poor pharmacokinetics. We report the synthesis of a library of 15 boron-containing analogs of fosmidomycin and their comprehensive evaluation as IspC inhibitors and antimicrobial agents. The compounds did not demonstrate significant activity against the intended IspC target, thus providing evidence that these boron moieties may have limited utility as phosphonate isosteres in this system. However, our investigation yielded unexpected and valuable antimicrobial discoveries. Several benzoxaborole compounds demonstrated significant activity against pathogenic microbes, including methicillin-resistant (MRSA), , and . Mechanistic studies confirmed that these compounds operate through alternative pathways distinct from MEP pathway inhibition. These results provide a foundation for the rational design of next-generation boron-containing antimicrobials with enhanced potency and selectivity against resistant pathogens, including MRSA.Keywords
Funding Information
- Saint Joseph's University
- Wellcome Trust
- University of Queensland
This publication has 48 references indexed in Scilit:
- New Paradigm in Ionization: Multiply Charged Ion Formation from a Solid Matrix without a Laser or VoltageAnalytical Chemistry, 2010
- Drying of Organic Solvents: Quantitative Evaluation of the Efficiency of Several DesiccantsThe Journal of Organic Chemistry, 2010
- The Mevalonate Pathway ofStaphylococcus aureusJournal of Bacteriology, 2009
- Studies Addressing the Importance of Charge in the Binding of Fosmidomycin‐Like Molecules to Deoxyxylulosephosphate ReductoisomeraseChemMedChem, 2008
- Synthesis of Unsaturated Organotrifluoroborates via Wittig and Horner−Wadsworth−Emmons OlefinationThe Journal of Organic Chemistry, 2006
- Synthesis of α-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- 1-Deoxy- d -Xylulose 5-Phosphate Reductoisomerase (IspC) from Mycobacterium tuberculosis : towards Understanding Mycobacterial Resistance to FosmidomycinJournal of Bacteriology, 2005
- Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomeraseBiochemical Journal, 2005
- The Crystal Structure of E.coli 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase in a Ternary Complex with the Antimalarial Compound Fosmidomycin and NADPH Reveals a Tight-binding Closed Enzyme ConformationJournal of Molecular Biology, 2005
- Crystallographic Structures of Two Bisphosphonate:1-Deoxyxylulose-5-Phosphate Reductoisomerase ComplexesJournal of the American Chemical Society, 2004